Switching Fluoroquinolones in Patients with Neutropenia May Increase Infection Risks: Presented at ICAAC
Switching Fluoroquinolones in Patients with Neutropenia May Increase Infection Risks: Presented at ICAAC
The investigators recommend that physicians exercise caution when considering a switch from one fluoroquinolone agent to another in patients with neutropenia who are on antibiotic prophylaxis.
Invitrogen Enters Into Worldwide Co-Marketing Agreement With genOway Focused On RNAi Services (Bioresearch Online)
Carlsbad, CA & Lyon, France - Invitrogen Corporation, a provider of essential life science technologies for disease research and drug discovery and genOway, a creator of genetically modified biological models announced the signing of a co-marketing agreement around RNAi related services.
Civil Disobedience Called to Oppose GMOs At WTO (AllAfrica.com)
International civil society groups have delivered a strong message to the sixth World Trade Organisation (WTO) ministerial meeting in a petition against genetically modified organisms (GMOs).
Archive: Thermal spring offers hope for eczema sufferers
Thermal spring offers hope for eczema sufferers by DIANNE SPENCER, Daily Mail The parents of four-year-old Oldham boy Ryan Knott can scarcely remember a time when their son hasn’t been plagued by the discomfort and constant itching of eczema.
Insurance Homeowners
Trackback by Anonymous — January 24, 2007 @ 19:10